• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Benzinga's Top Ratings Upgrades, Downgrades For May 4, 2023

    5/4/23 11:00:45 AM ET
    $ABSI
    $BLDR
    $BLKB
    $CERE
    Biotechnology: Commercial Physical & Biological Resarch
    Health Care
    RETAIL: Building Materials
    Consumer Discretionary
    Get the next $ABSI alert in real time by email

    Upgrades

    According to OTR Global, the prior rating for Ritchie Bros Auctioneers Inc (NYSE:RBA) was changed from Mixed to Positive. For the fourth quarter, Ritchie Bros Auctioneers had an EPS of $0.68, compared to year-ago quarter EPS of $0.50. The current stock performance of Ritchie Bros Auctioneers shows a 52-week-high of $72.68 and a 52-week-low of $48.75. Moreover, at the end of the last trading period, the closing price was at $56.27.

    For Louisiana-Pacific Corp (NYSE:LPX), TD Cowen upgraded the previous rating of Hold to Buy. In the first quarter, Louisiana-Pacific showed an EPS of $0.34, compared to $5.08 from the year-ago quarter. The current stock performance of Louisiana-Pacific shows a 52-week-high of $78.09 and a 52-week-low of $48.20. Moreover, at the end of the last trading period, the closing price was at $61.97.

    For Builders FirstSource Inc (NYSE:BLDR), RBC Capital upgraded the previous rating of Sector Perform to Outperform. For the first quarter, Builders FirstSource had an EPS of $2.96, compared to year-ago quarter EPS of $3.90. The stock has a 52-week-high of $107.81 and a 52-week-low of $48.94. At the end of the last trading period, Builders FirstSource closed at $107.46.

    For Verisk Analytics Inc (NASDAQ:VRSK), B of A Securities upgraded the previous rating of Underperform to Buy. In the first quarter, Verisk Analytics showed an EPS of $1.29, compared to $1.34 from the year-ago quarter. The current stock performance of Verisk Analytics shows a 52-week-high of $206.89 and a 52-week-low of $156.07. Moreover, at the end of the last trading period, the closing price was at $203.97.

    For Ionis Pharmaceuticals Inc (NASDAQ:IONS), Citigroup upgraded the previous rating of Sell to Neutral. For the first quarter, Ionis Pharmaceuticals had an EPS of $0.68, compared to year-ago quarter EPS of $0.27. The stock has a 52-week-high of $48.82 and a 52-week-low of $31.46. At the end of the last trading period, Ionis Pharmaceuticals closed at $34.73.

    For Neurocrine Biosciences Inc (NASDAQ:NBIX), Guggenheim upgraded the previous rating of Neutral to Buy. Neurocrine Biosciences earned $0.51 in the first quarter, compared to $0.30 in the year-ago quarter. The current stock performance of Neurocrine Biosciences shows a 52-week-high of $129.00 and a 52-week-low of $75.27. Moreover, at the end of the last trading period, the closing price was at $98.62.

    According to Summit Insights Group, the prior rating for Qorvo Inc (NASDAQ:QRVO) was changed from Hold to Buy. Qorvo earned $0.26 in the fourth quarter, compared to $3.12 in the year-ago quarter. At the moment, the stock has a 52-week-high of $121.21 and a 52-week-low of $75.58. Qorvo closed at $93.62 at the end of the last trading period.

    For Procore Technologies Inc (NYSE:PCOR), Goldman Sachs upgraded the previous rating of Neutral to Buy. Procore Technologies earned $0.01 in the first quarter, compared to $0.15 in the year-ago quarter. The current stock performance of Procore Technologies shows a 52-week-high of $68.56 and a 52-week-low of $40.12. Moreover, at the end of the last trading period, the closing price was at $53.18.

    TD Securities upgraded the previous rating for Louisiana-Pacific Corp (NYSE:LPX) from Hold to Buy. For the first quarter, Louisiana-Pacific had an EPS of $0.34, compared to year-ago quarter EPS of $5.08. The current stock performance of Louisiana-Pacific shows a 52-week-high of $78.09 and a 52-week-low of $48.20. Moreover, at the end of the last trading period, the closing price was at $61.97.

    According to Wells Fargo, the prior rating for Cerevel Therapeutics Holdings Inc (NASDAQ:CERE) was changed from Equal-Weight to Overweight. Cerevel Therapeutics Hldg earned $0.67 in the first quarter, compared to $0.46 in the year-ago quarter. The stock has a 52-week-high of $41.43 and a 52-week-low of $19.88. At the end of the last trading period, Cerevel Therapeutics Hldg closed at $31.92.

    According to B. Riley Securities, the prior rating for Hersha Hospitality Trust (NYSE:HT) was changed from Neutral to Buy. In the first quarter, Hersha Hospitality showed an EPS of $0.02, compared to $0.06 from the year-ago quarter. The current stock performance of Hersha Hospitality shows a 52-week-high of $12.13 and a 52-week-low of $5.75. Moreover, at the end of the last trading period, the closing price was at $6.02.

    For Green Brick Partners Inc (NYSE:GRBK), B. Riley Securities upgraded the previous rating of Neutral to Buy. Green Brick Partners earned $1.37 in the first quarter, compared to $1.20 in the year-ago quarter. The current stock performance of Green Brick Partners shows a 52-week-high of $38.13 and a 52-week-low of $16.80. Moreover, at the end of the last trading period, the closing price was at $37.17.

    For Blackbaud Inc (NASDAQ:BLKB), Baird upgraded the previous rating of Neutral to Outperform. In the first quarter, Blackbaud showed an EPS of $0.72, compared to $0.57 from the year-ago quarter. At the moment, the stock has a 52-week-high of $69.77 and a 52-week-low of $43.54. Blackbaud closed at $67.33 at the end of the last trading period.

    According to Raymond James, the prior rating for Weave Communications Inc (NYSE:WEAV) was changed from Market Perform to Outperform. In the first quarter, Weave Communications showed an EPS of $0.05, compared to $0.16 from the year-ago quarter. The stock has a 52-week-high of $6.93 and a 52-week-low of $2.99. At the end of the last trading period, Weave Communications closed at $4.26.

    According to Raymond James, the prior rating for Wix.com Ltd (NASDAQ:WIX) was changed from Market Perform to Outperform. For the fourth quarter, Wix.com had an EPS of $0.61, compared to year-ago quarter EPS of $0.37. The current stock performance of Wix.com shows a 52-week-high of $101.55 and a 52-week-low of $53.12. Moreover, at the end of the last trading period, the closing price was at $75.36.

    According to Goldman Sachs, the prior rating for Design Therapeutics Inc (NASDAQ:DSGN) was changed from Sell to Neutral. In the fourth quarter, Design Therapeutics showed an EPS of $0.31, compared to $0.20 from the year-ago quarter. At the moment, the stock has a 52-week-high of $26.30 and a 52-week-low of $4.90. Design Therapeutics closed at $7.19 at the end of the last trading period.

    According to Goldman Sachs, the prior rating for Cemex SAB de CV (NYSE:CX) was changed from Neutral to Buy. Cemex earned $0.15 in the first quarter, compared to $0.13 in the year-ago quarter. The stock has a 52-week-high of $6.73 and a 52-week-low of $3.20. At the end of the last trading period, Cemex closed at $6.31.

    See all analyst ratings upgrades.

    Downgrades

    According to B of A Securities, the prior rating for Upwork Inc (NASDAQ:UPWK) was changed from Buy to Neutral. Upwork earned $0.01 in the first quarter, compared to $0.03 in the year-ago quarter. The stock has a 52-week-high of $25.05 and a 52-week-low of $7.95. At the end of the last trading period, Upwork closed at $8.14.

    For Incyte Corp (NASDAQ:INCY), B of A Securities downgraded the previous rating of Buy to Neutral. Incyte earned $0.37 in the first quarter, compared to $0.55 in the year-ago quarter. At the moment, the stock has a 52-week-high of $86.29 and a 52-week-low of $65.07. Incyte closed at $68.04 at the end of the last trading period.

    For QuinStreet Inc (NASDAQ:QNST), Craig-Hallum downgraded the previous rating of Buy to Hold. In the third quarter, QuinStreet showed an EPS of $0.11, compared to $0.09 from the year-ago quarter. The stock has a 52-week-high of $18.18 and a 52-week-low of $8.29. At the end of the last trading period, QuinStreet closed at $9.70.

    Susquehanna downgraded the previous rating for Frontier Group Holdings Inc (NASDAQ:ULCC) from Positive to Neutral. Frontier Group Holdings earned $0.05 in the first quarter, compared to $0.50 in the year-ago quarter. At the moment, the stock has a 52-week-high of $15.24 and a 52-week-low of $8.19. Frontier Group Holdings closed at $9.54 at the end of the last trading period.

    DA Davidson downgraded the previous rating for PacWest Bancorp (NASDAQ:PACW) from Buy to Neutral. In the first quarter, PacWest Banc showed an EPS of $0.66, compared to $1.01 from the year-ago quarter. The stock has a 52-week-high of $34.68 and a 52-week-low of $5.00. At the end of the last trading period, PacWest Banc closed at $6.42.

    According to Wedbush, the prior rating for Diebold Nixdorf Inc (NYSE:DBD) was changed from Outperform to Neutral. Diebold Nixdorf earned $0.85 in the first quarter, compared to $1.61 in the year-ago quarter. The stock has a 52-week-high of $5.26 and a 52-week-low of $0.44. At the end of the last trading period, Diebold Nixdorf closed at $0.45.

    For SiTime Corp (NASDAQ:SITM), Needham downgraded the previous rating of Buy to Hold. For the first quarter, SiTime had an EPS of $0.09, compared to year-ago quarter EPS of $0.94. At the moment, the stock has a 52-week-high of $234.44 and a 52-week-low of $73.10. SiTime closed at $106.54 at the end of the last trading period.

    According to TD Cowen, the prior rating for Spirit AeroSystems Holdings Inc (NYSE:SPR) was changed from Outperform to Market Perform. For the first quarter, Spirit AeroSystems Hldgs had an EPS of $1.69, compared to year-ago quarter EPS of $0.03. The current stock performance of Spirit AeroSystems Hldgs shows a 52-week-high of $43.50 and a 52-week-low of $21.15. Moreover, at the end of the last trading period, the closing price was at $26.28.

    For TriplePoint Venture Growth BDC Corp (NYSE:TPVG), Wells Fargo downgraded the previous rating of Overweight to Equal-Weight. For the first quarter, TriplePoint Venture Gwth had an EPS of $0.53, compared to year-ago quarter EPS of $0.44. The stock has a 52-week-high of $16.37 and a 52-week-low of $10.10. At the end of the last trading period, TriplePoint Venture Gwth closed at $10.73.

    For Builders FirstSource Inc (NYSE:BLDR), Baird downgraded the previous rating of Outperform to Neutral. For the first quarter, Builders FirstSource had an EPS of $2.96, compared to year-ago quarter EPS of $3.90. At the moment, the stock has a 52-week-high of $107.81 and a 52-week-low of $48.94. Builders FirstSource closed at $107.46 at the end of the last trading period.

    According to Baird, the prior rating for IVERIC bio Inc (NASDAQ:ISEE) was changed from Outperform to Neutral. For the fourth quarter, IVERIC bio had an EPS of $0.47, compared to year-ago quarter EPS of $0.29. At the moment, the stock has a 52-week-high of $38.25 and a 52-week-low of $8.88. IVERIC bio closed at $37.21 at the end of the last trading period.

    According to Raymond James, the prior rating for Revolve Group Inc (NYSE:RVLV) was changed from Outperform to Market Perform. In the first quarter, Revolve Gr showed an EPS of $0.19, compared to $0.30 from the year-ago quarter. The stock has a 52-week-high of $44.32 and a 52-week-low of $19.71. At the end of the last trading period, Revolve Gr closed at $20.01.

    According to Citigroup, the prior rating for Wingstop Inc (NASDAQ:WING) was changed from Buy to Neutral. For the first quarter, Wingstop had an EPS of $0.59, compared to year-ago quarter EPS of $0.34. The stock has a 52-week-high of $221.30 and a 52-week-low of $67.75. At the end of the last trading period, Wingstop closed at $217.95.

    According to Goldman Sachs, the prior rating for Fulcrum Therapeutics Inc (NASDAQ:FULC) was changed from Buy to Neutral. In the fourth quarter, Fulcrum Therapeutics showed an EPS of $0.50, compared to $0.58 from the year-ago quarter. The current stock performance of Fulcrum Therapeutics shows a 52-week-high of $15.00 and a 52-week-low of $2.25. Moreover, at the end of the last trading period, the closing price was at $2.93.

    According to Jefferies, the prior rating for DHT Holdings Inc (NYSE:DHT) was changed from Buy to Hold. For the first quarter, DHT Holdings had an EPS of $0.23, compared to year-ago quarter EPS of $0.10. The stock has a 52-week-high of $12.13 and a 52-week-low of $4.99. At the end of the last trading period, DHT Holdings closed at $9.03.

    See all analyst ratings downgrades.

    Initiations

    With a Buy rating, UBS initiated coverage on Ferguson PLC (NYSE:FERG). The price target seems to have been set at $165.00 for Ferguson. For the second quarter, Ferguson had an EPS of $1.91, compared to year-ago quarter EPS of $1.93. At the moment, the stock has a 52-week-high of $149.81 and a 52-week-low of $99.24. Ferguson closed at $139.50 at the end of the last trading period.

    With a Buy rating, HC Wainwright & Co. initiated coverage on Absci Corp (NASDAQ:ABSI). The price target seems to have been set at $4.00 for Absci. Absci earned $0.21 in the fourth quarter, compared to $0.28 in the year-ago quarter. The stock has a 52-week-high of $7.03 and a 52-week-low of $1.17. At the end of the last trading period, Absci closed at $1.25.

    DA Davidson initiated coverage on ZoomInfo Technologies Inc (NASDAQ:ZI) with a Buy rating. The price target for ZoomInfo Technologies is set to $30.00. ZoomInfo Technologies earned $0.24 in the first quarter, compared to $0.18 in the year-ago quarter. At the moment, the stock has a 52-week-high of $54.42 and a 52-week-low of $20.72. ZoomInfo Technologies closed at $21.45 at the end of the last trading period.

    See all analyst ratings initiations.

    Get the next $ABSI alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ABSI
    $BLDR
    $BLKB
    $CERE

    CompanyDatePrice TargetRatingAnalyst
    Wingstop Inc.
    $WING
    2/10/2026$285.00Buy → Hold
    TD Cowen
    Wingstop Inc.
    $WING
    2/10/2026$325.00Strong Buy → Outperform
    Raymond James
    Frontier Group Holdings Inc.
    $ULCC
    2/10/2026$6.00Buy → Hold
    Deutsche Bank
    Cemex S.A.B. de C.V. Sponsored ADR
    $CX
    2/6/2026$12.80Buy → Hold
    HSBC Securities
    Procore Technologies Inc.
    $PCOR
    2/5/2026$87.00 → $67.00Outperform
    BMO Capital Markets
    Louisiana-Pacific Corporation
    $LPX
    2/5/2026$15.00Outperform
    Oppenheimer
    Incyte Corp.
    $INCY
    2/5/2026$135.00Buy
    H.C. Wainwright
    Verisk Analytics Inc.
    $VRSK
    2/4/2026$233.00Market Perform → Outperform
    BMO Capital Markets
    More analyst ratings

    $ABSI
    $BLDR
    $BLKB
    $CERE
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    December 13, 2024 - FDA Approves New Treatment for Congenital Adrenal Hyperplasia

    For Immediate Release: December 13, 2024 Today, the U.S. Food and Drug Administration approved Crenessity (crinecerfont) to be used together with glucocorticoids (steroids) to control androgen (a testosterone-like hormone) levels in adults and pediatric patients 4 years of age and older with classic congenital adrenal hyperplasia (CAH).“Today’s approval provides an important advance for patients with classic con

    12/13/24 5:54:17 PM ET
    $NBIX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    FDA Approval for IZERVAY issued to IVERIC BIO, INC.

    Submission status for IVERIC BIO, INC.'s drug IZERVAY (ORIG-1) with active ingredient AVACINCAPTAD PEGOL has changed to 'Approval' on 08/04/2023. Application Category: NDA, Application Number: 217225, Application Classification: Type 1 - New Molecular Entity

    8/9/23 8:37:19 AM ET
    $ISEE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for JAKAFI issued to INCYTE CORP

    Submission status for INCYTE CORP's drug JAKAFI (SUPPL-25) with active ingredient RUXOLITINIB PHOSPHATE has changed to 'Approval' on 09/27/2021. Application Category: NDA, Application Number: 202192, Application Classification: Labeling

    9/28/21 5:20:01 AM ET
    $INCY
    Biotechnology: Commercial Physical & Biological Resarch
    Health Care

    $ABSI
    $BLDR
    $BLKB
    $CERE
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Wingstop downgraded by TD Cowen with a new price target

    TD Cowen downgraded Wingstop from Buy to Hold and set a new price target of $285.00

    2/10/26 8:00:55 AM ET
    $WING
    Restaurants
    Consumer Discretionary

    Wingstop downgraded by Raymond James with a new price target

    Raymond James downgraded Wingstop from Strong Buy to Outperform and set a new price target of $325.00

    2/10/26 8:00:55 AM ET
    $WING
    Restaurants
    Consumer Discretionary

    Frontier Group Holdings downgraded by Deutsche Bank with a new price target

    Deutsche Bank downgraded Frontier Group Holdings from Buy to Hold and set a new price target of $6.00

    2/10/26 7:47:54 AM ET
    $ULCC
    Air Freight/Delivery Services
    Consumer Discretionary

    $ABSI
    $BLDR
    $BLKB
    $CERE
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Neurocrine Biosciences Reports Fourth-Quarter and Full-Year 2025 Financial Results and Provides Financial Expectations for 2026

    Total Fourth-Quarter and Full-Year 2025 Net Product Sales of $798.3 Million and $2.83 Billion, Representing Year-Over-Year Growth of 29% and 22%, Respectively INGREZZA® (valbenazine) Full Year 2026 Net Product Sales Guidance of $2.7 - $2.8 Billion SAN DIEGO, Feb. 11, 2026 /PRNewswire/ -- Neurocrine Biosciences, Inc. (NASDAQ:NBIX) today announced its financial results for the fourth quarter ended December 31, 2025. "Our 2025 performance reflects the strength and durability of our commercial business and meaningful progress we are making transforming Neurocrine into a broader, m

    2/11/26 4:01:00 PM ET
    $NBIX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Frontier Announces Fleet Optimization Transaction with AerCap

    Non-Binding Agreement for 24 Aircraft Returns and 10 Future Sale-Leaseback Transactions DENVER, Feb. 11, 2026   /PRNewswire/ -- Frontier Group Holdings, Inc. (NASDAQ:ULCC) ("Frontier" or the "Company"), parent company of Frontier Airlines, Inc., announced today a non-binding agreement with AerCap Holdings N.V. (NYSE:AER) ("AerCap") for the early return of 24 A320neo aircraft currently in operation, all of which have lease agreements scheduled to expire within the next two to eight years. The 24 returns are expected to be completed during the second quarter of 2026. In turn, AerCap will agree to 10 future sale-leaseback transactions for deliveries scheduled for the years 2028 and 2029. These

    2/11/26 8:01:00 AM ET
    $AER
    $ULCC
    Diversified Commercial Services
    Consumer Discretionary
    Air Freight/Delivery Services

    Frontier Airlines Reports Fourth Quarter 2025 Financial Results

    DENVER, Feb. 11, 2026 /PRNewswire/ -- Frontier Group Holdings, Inc. (NASDAQ:ULCC), parent company of Frontier Airlines, Inc., today reported financial results for the fourth quarter and full year 2025 and issued guidance for the first quarter and full year 2026. Highlights: Total revenue was $997 million on capacity which was flat to the corresponding 2024 quarterRevenue per available seat mile ("RASM") was 10.17 cents, while RASM on a stage adjusted basis to 1,000 miles was 9.61 cents, slightly higher than the comparable 2024 quarterCost per available seat mile ("CASM") was 9

    2/11/26 8:00:00 AM ET
    $ULCC
    Air Freight/Delivery Services
    Consumer Discretionary

    $ABSI
    $BLDR
    $BLKB
    $CERE
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President and CIO Srivastava Sajal bought $263,432 worth of shares (39,799 units at $6.62) (SEC Form 4)

    4 - TriplePoint Venture Growth BDC Corp. (0001580345) (Issuer)

    1/13/26 10:50:11 AM ET
    $TPVG
    Other Consumer Services
    Consumer Discretionary

    Chief Executive Officer Labe James bought $263,432 worth of shares (39,799 units at $6.62) (SEC Form 4)

    4 - TriplePoint Venture Growth BDC Corp. (0001580345) (Issuer)

    1/13/26 10:50:43 AM ET
    $TPVG
    Other Consumer Services
    Consumer Discretionary

    President and CIO Srivastava Sajal bought $309,772 worth of shares (47,710 units at $6.49) (SEC Form 4)

    4 - TriplePoint Venture Growth BDC Corp. (0001580345) (Issuer)

    1/9/26 5:43:59 PM ET
    $TPVG
    Other Consumer Services
    Consumer Discretionary

    $ABSI
    $BLDR
    $BLKB
    $CERE
    SEC Filings

    View All

    Qorvo Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

    8-K - Qorvo, Inc. (0001604778) (Filer)

    2/11/26 5:16:35 PM ET
    $QRVO
    Semiconductors
    Technology

    Amendment: SEC Form SCHEDULE 13G/A filed by Weave Communications Inc.

    SCHEDULE 13G/A - Weave Communications, Inc. (0001609151) (Subject)

    2/11/26 5:09:31 PM ET
    $WEAV
    Computer Software: Prepackaged Software
    Technology

    SEC Form 6-K filed by Cemex S.A.B. de C.V. Sponsored ADR

    6-K - CEMEX SAB DE CV (0001076378) (Filer)

    2/11/26 5:00:10 PM ET
    $CX
    Building Materials
    Industrials

    $ABSI
    $BLDR
    $BLKB
    $CERE
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    VP, Controller & CAO Davis Leslie E covered exercise/tax liability with 47 shares, decreasing direct ownership by 2% to 2,500 units (SEC Form 4)

    4 - LOUISIANA-PACIFIC CORP (0000060519) (Issuer)

    2/11/26 6:15:36 PM ET
    $LPX
    Forest Products
    Basic Materials

    SVP, Chief Commercial Officer Sichling Craig M covered exercise/tax liability with 224 shares, decreasing direct ownership by 5% to 3,970 units (SEC Form 4)

    4 - LOUISIANA-PACIFIC CORP (0000060519) (Issuer)

    2/11/26 6:13:32 PM ET
    $LPX
    Forest Products
    Basic Materials

    EVP, CFO Haughie Alan covered exercise/tax liability with 1,221 shares, decreasing direct ownership by 0.92% to 131,260 units (SEC Form 4)

    4 - LOUISIANA-PACIFIC CORP (0000060519) (Issuer)

    2/11/26 6:11:09 PM ET
    $LPX
    Forest Products
    Basic Materials

    $ABSI
    $BLDR
    $BLKB
    $CERE
    Leadership Updates

    Live Leadership Updates

    View All

    Frontier Group Holdings, Inc. Announces New Board Member

    DENVER, Feb. 9, 2026 /PRNewswire/ -- Frontier Group Holdings, Inc. ((ULCC), parent company of Frontier Airlines, Inc., today announced the appointment of Anthony Salcido to the company's Board of Directors. "We are very pleased to have Mr. Salcido join the Frontier Board of Directors," said William A. Franke, chairman of Frontier Group Holdings, Inc. "His deep experience in corporate financial leadership and other key areas of financial discipline will be of tremendous benefit to our organization." Mr. Salcido served as the Chief Accounting Officer of Toyota Motors North Ameri

    2/9/26 4:05:00 PM ET
    $ULCC
    Air Freight/Delivery Services
    Consumer Discretionary

    Verisk Names Steven Kauderer President of Claims Solutions

    JERSEY CITY, N.J., Feb. 09, 2026 (GLOBE NEWSWIRE) -- Verisk (NASDAQ:VRSK), a leading strategic data analytics and technology partner to the global insurance industry, today announced that Steven Kauderer has been named president of its Claims Solutions business, effective immediately.  Kauderer leads Verisk's Claims Solutions team in delivering insights and innovative solutions that help insurers and claims ecosystem participants streamline the claims process for policyholders with greater accuracy, efficiency and speed. He reports to Lee Shavel, president and CEO of Verisk.  "We're excited to welcome Steve to Verisk," Shavel said. "Our clients and colleagues will immediately benefit fro

    2/9/26 8:30:00 AM ET
    $VRSK
    Diversified Commercial Services
    Industrials

    SiTime Expands Board of Directors with the Appointment of Faraj Aalaei

    SiTime Corporation (NASDAQ:SITM), the Precision Timing company, today announced it is expanding the company's Board of Directors with the appointment of Mr. Faraj Aalaei, founder, chairman and CEO of Cognichip, Inc. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260120336374/en/Faraj Aalaei, Founder, Chairman and CEO of Cognichip, Inc. "Faraj is a proven entrepreneur, having envisioned, built and successfully scaled several semiconductor businesses—Centillium and Aquantia stand out as prime examples of his leadership," said Rajesh Vashist, chairman and CEO of SiTime. "Faraj's expertise in AI, networking and communications aligns

    1/21/26 4:05:00 PM ET
    $SITM
    Semiconductors
    Technology

    $ABSI
    $BLDR
    $BLKB
    $CERE
    Financials

    Live finance-specific insights

    View All

    Neurocrine Biosciences Reports Fourth-Quarter and Full-Year 2025 Financial Results and Provides Financial Expectations for 2026

    Total Fourth-Quarter and Full-Year 2025 Net Product Sales of $798.3 Million and $2.83 Billion, Representing Year-Over-Year Growth of 29% and 22%, Respectively INGREZZA® (valbenazine) Full Year 2026 Net Product Sales Guidance of $2.7 - $2.8 Billion SAN DIEGO, Feb. 11, 2026 /PRNewswire/ -- Neurocrine Biosciences, Inc. (NASDAQ:NBIX) today announced its financial results for the fourth quarter ended December 31, 2025. "Our 2025 performance reflects the strength and durability of our commercial business and meaningful progress we are making transforming Neurocrine into a broader, m

    2/11/26 4:01:00 PM ET
    $NBIX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Frontier Airlines Reports Fourth Quarter 2025 Financial Results

    DENVER, Feb. 11, 2026 /PRNewswire/ -- Frontier Group Holdings, Inc. (NASDAQ:ULCC), parent company of Frontier Airlines, Inc., today reported financial results for the fourth quarter and full year 2025 and issued guidance for the first quarter and full year 2026. Highlights: Total revenue was $997 million on capacity which was flat to the corresponding 2024 quarterRevenue per available seat mile ("RASM") was 10.17 cents, while RASM on a stage adjusted basis to 1,000 miles was 9.61 cents, slightly higher than the comparable 2024 quarterCost per available seat mile ("CASM") was 9

    2/11/26 8:00:00 AM ET
    $ULCC
    Air Freight/Delivery Services
    Consumer Discretionary

    Ferguson to Issue Results for the Period Ended December 31, 2025, as well as provide an Update on Market Opportunities and Strategy on February 24, 2026

    Ferguson Enterprises Inc. (NYSE:FERG, LSE: FERG)) announces today that it will issue its results for the period ended December 31, 2025 and provide an update on market opportunities and strategy on Tuesday, February 24, 2026. The results will be available on Ferguson's website at corporate.ferguson.com at 6:45 a.m. ET/11:45 a.m. GMT. A conference call and webcast of the analyst and investor presentation will be broadcast at 8:30 a.m. ET/1:30 p.m. GMT on the same day. Participants can register for the webcast at corporate.ferguson.com. A slide presentation that accompanies the event will be available 15 minutes prior to the start time at corporate.ferguson.com on the Events, Results and

    2/11/26 6:45:00 AM ET
    $FERG
    Miscellaneous

    $ABSI
    $BLDR
    $BLKB
    $CERE
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Weave Communications Inc.

    SC 13D/A - Weave Communications, Inc. (0001609151) (Subject)

    12/9/24 7:11:00 PM ET
    $WEAV
    Computer Software: Prepackaged Software
    Technology

    Amendment: SEC Form SC 13G/A filed by Upwork Inc.

    SC 13G/A - UPWORK, INC (0001627475) (Subject)

    12/9/24 6:02:26 AM ET
    $UPWK
    EDP Services
    Technology

    Amendment: SEC Form SC 13D/A filed by Weave Communications Inc.

    SC 13D/A - Weave Communications, Inc. (0001609151) (Subject)

    11/27/24 4:31:49 PM ET
    $WEAV
    Computer Software: Prepackaged Software
    Technology